EUVIMEDEUVIMED entdecken
Crossref

Efficient Synthesis of Chirally Enriched 1H-Imidazo[1,2-b]pyrazole- and 4H-Imidazo[1,2-b][1,2,4]triazole-Based Bioactive Glycohybrids

Ram Sagar, Vinay Kumar Mishra, Ghanshyam Tiwari, Ashish Khanna, Rajdeep Tyagi

Synthesis · 15.03.2024 · 56 (06) · 1017-1025

DOI: 10.1055/a-2157-9100 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Synthesis, erschienen am 15.03.2024. Verfasst von Ram Sagar und 4 weiteren Autor:innen. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 56 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Carbohydrates, traditionally known for their energy-providing role, have gained significant attention in drug discovery due to their diverse bioactivities and stereodiversity. However, pure carbohydrate molecules often exhibit limited bioactivity and suboptimal chemical and physical characteristics. To address these challenges, bioactive scaffolds have been incorporated into carbohydrate to enhance their bioactivity and improve their overall properties. Among the various heterocyclic structural motifs known for their pharmacological properties, imidazo-pyrazole and imidazo-triazole skeleton have gained larger attention among synthetic and medicinal chemists as they possess good biological and pharmacological properties. The incorporation of these bioactive scaffolds with carbohydrates adopting developed efficient synthetic protocol to synthesize new class of imidazo-pyrazole and imidazo-triazole glycohybrid molecules is reported. The carbohydrate-derived α-iodo-2,3-dihydro-4H-pyran-4-ones have been identified as suitable precursors, which were coupled with various aminopyrazoles and aminotriazoles to obtain designed glycohybrids. Thus, various imidazo-pyrazole and imidazo-triazole based glycohybrids have been prepared efficiently in good to excellent yields. These new glycohybrids were evaluated for their anticancer activity and selected compounds were found to possess submicromolar anticancer activity against MCF-7 breast cancer cell line. These molecules could potentially be developed as new chemical entities in pharmaceutical chemistry and may encourage the use of carbohydrates in stereo-divergent synthesis and drug discovery processes.

Zitieren

APA

Sagar, R., Mishra, V. K., Tiwari, G., Khanna, A., & Tyagi, R. (2024). Efficient Synthesis of Chirally Enriched 1H-Imidazo[1,2-b]pyrazole- and 4H-Imidazo[1,2-b][1,2,4]triazole-Based Bioactive Glycohybrids. Synthesis, 56(06), 1017-1025. https://doi.org/10.1055/a-2157-9100

Vancouver

Sagar R, Mishra VK, Tiwari G, Khanna A, Tyagi R. Efficient Synthesis of Chirally Enriched 1H-Imidazo[1,2-b]pyrazole- and 4H-Imidazo[1,2-b][1,2,4]triazole-Based Bioactive Glycohybrids. Synthesis. 2024;56(06):1017-1025. doi:10.1055/a-2157-9100

BibTeX
@article{Sagar2024,
  author = {Sagar, Ram and Mishra, Vinay Kumar and Tiwari, Ghanshyam and Khanna, Ashish and Tyagi, Rajdeep},
  title = {Efficient Synthesis of Chirally Enriched 1H-Imidazo[1,2-b]pyrazole- and 4H-Imidazo[1,2-b][1,2,4]triazole-Based Bioactive Glycohybrids},
  journal = {Synthesis},
  year = {2024},
  volume = {56},
  number = {06},
  pages = {1017--1025},
  doi = {10.1055/a-2157-9100}
}
Kostenlos starten →